Rite Aid (NYSE:RAD) has been one of Wall Street's top performers this year as the company's restructuring plan has returned it to profitability.
However, Rite Aid's plans to improve working capital and profitability by outsourcing generic drug purchasing to McKesson (NYSE:MCK) hit a snag last quarter that weighed on profit.
In the following slideshow, I've included 18 quotes from Rite Aid's management that provide insight into five subjects: the McKesson headwind, Obamacare's impact, expansion plans, health care clinics, and guidance for the remainder of this year.
Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends McKesson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
What Will Strong Nerf Sales on Amazon Mean for Hasbro?
Amazon said Hasbro's Nerf N-Strike Elite Strongarm Blaster was the best-selling toy on Amazon over the holidays. That won't necessarily translate to a blockbuster quarter for the toymaker.
Are Strong Sales of Robotic Vacuums on Amazon Good News for iRobot?
Robotic vacuums were among the best-selling home items on Amazon over the holidays. Will that translate into strong results for iRobot?
Will Roku's TV Sales on Amazon Move the Needle?
Roku had two of the top-selling televisions on Amazon over the holidays, but what will that mean for Roku's earnings?